Erratum to: Synthesis and biologic activities of some novel heterocyclic chalcone derivatives

[1]  C. Khobragade,et al.  Synthesis and biological evaluation of simple methoxylated chalcones as anticancer, anti-inflammatory and antioxidant agents. , 2010, Bioorganic & medicinal chemistry.

[2]  W. Krol,et al.  Chalcones Enhance TRAIL-Induced Apoptosis in Prostate Cancer Cells , 2009, International journal of molecular sciences.

[3]  R. Butcher,et al.  (2E)-1-(3-Chlorophenyl)-3-(4-chlorophenyl)prop-2-en-1-one , 2009, Acta Crystallographica Section E.

[4]  H. F. Zohdi,et al.  Atom-Efficient, Solvent-Free, Green Synthesis of Chalcones by Grinding , 2009 .

[5]  M. A. Radwan,et al.  Synthesis of some pyridine, thiopyrimidine, and isoxazoline derivatives based on the pyrrole moiety , 2009 .

[6]  J. Santibañez,et al.  Structural Antitumoral Activity Relationships of Synthetic Chalcones , 2009, International journal of molecular sciences.

[7]  Dong-Qing Li,et al.  3-(4-Methoxyphenyl)-1-(2-pyrrolyl)prop-2-en-1-one , 2008, Acta crystallographica. Section E, Structure reports online.

[8]  A. Brancale,et al.  Design, synthesis, and biological evaluation of thiophene analogues of chalcones. , 2008, Bioorganic & medicinal chemistry.

[9]  G. Achanta,et al.  A Boronic-Chalcone Derivative Exhibits Potent Anticancer Activity through Inhibition of the Proteasome , 2006, Molecular Pharmacology.

[10]  A. Khalil,et al.  Stereoselective Crossed‐Aldol Condensation of Hetarylmethyl Ketones with Aromatic Aldehydes in Water: Synthesis of (2E)‐3‐Aryl‐1‐hetarylprop‐2‐en‐1‐ones. , 2006 .

[11]  K. Poole.  Efflux-mediated antimicrobial resistance. , 2005, The Journal of antimicrobial chemotherapy.

[12]  K. Schønning,et al.  Cationic chalcone antibiotics. Design, synthesis, and mechanism of action. , 2005, Journal of medicinal chemistry.

[13]  J. Vondráček,et al.  Chemoprotective and toxic potentials of synthetic and natural chalcones and dihydrochalcones in vitro. , 2005, Toxicology.

[14]  K. Schønning,et al.  Synthesis of prenylated benzaldehydes and their use in the synthesis of analogues of licochalcone A. , 2004, European journal of medicinal chemistry.

[15]  Patrick A. Curmi,et al.  Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain , 2004, Nature.

[16]  H. Kjaergaard,et al.  Hydrogen-bonded rotamers of 2′,4′,6′-trihydroxy-3′-formyldihydrochalcone, an intermediate in the synthesis of a dihydrochalcone from Leptospermum recurvum , 2003 .

[17]  T. Fukai,et al.  Anti-Helicobacter pylori flavonoids from licorice extract. , 2002, Life sciences.

[18]  Makio Kobayashi,et al.  Antibacterial Activity of Licochalcone A against Spore-Forming Bacteria , 2002, Antimicrobial Agents and Chemotherapy.

[19]  Ming Chen,et al.  In vitro antimycobacterial and antilegionella activity of licochalcone A from Chinese licorice roots. , 2002, Planta medica.

[20]  H. Elsohly,et al.  Dihydrochalcones from Piper longicaudatum. , 2001, Planta medica.

[21]  T. Tsuchiya,et al.  Phenolic constituents of licorice. VIII. Structures of glicophenone and glicoisoflavanone, and effects of licorice phenolics on methicillin-resistant Staphylococcus aureus. , 2000, Chemical & pharmaceutical bulletin.

[22]  G. Kaatz,et al.  Introduction of a norA Promoter Region Mutation into the Chromosome of a Fluoroquinolone-Susceptible Strain ofStaphylococcus aureus Using Plasmid Integration , 1999, Antimicrobial Agents and Chemotherapy.

[23]  Louis J. Farrugia,et al.  WinGX suite for small-molecule single-crystal crystallography , 1999 .

[24]  J. J. Meyer,et al.  Pinocembrin Chalcone: An Antibacterial Compound from Helichrysum trilineatum , 1998, Planta medica.

[25]  Louis J. Farrugia,et al.  ORTEP-3 for Windows - a version of ORTEP-III with a Graphical User Interface (GUI) , 1997 .

[26]  G. Kaatz,et al.  Inducible NorA-mediated multidrug resistance in Staphylococcus aureus , 1995, Antimicrobial agents and chemotherapy.

[27]  M. Nardelli,et al.  PARST95 – an update to PARST: a system of Fortran routines for calculating molecular structure parameters from the results of crystal structure analyses , 1995 .

[28]  G. Kaatz,et al.  Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus , 1993, Antimicrobial Agents and Chemotherapy.

[29]  G. Kaatz,et al.  Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter , 1993, Antimicrobial Agents and Chemotherapy.

[30]  S. Levy,et al.  Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[31]  E. Wong.  The role of chalcones and flavanones in flavonoid biosynthesis , 1968 .

[32]  Hiroshi Nikaido,et al.  Efflux-Mediated Drug Resistance in Bacteria , 2012, Drugs.

[33]  K. Ilango,et al.  Synthesis and In-vitro anti-cancer activity of some substituted Chalcone derivatives , 2010 .

[34]  B. Ramesh,et al.  SYNTHESIS AND ANTIDEPRESSANT ACTIVITY OF SOME NEW 3-(2''-HYDROXY NAPHTHALEN-1''-YL)-5-PHENYL-2- ISOXAZOLINES , 2007 .

[35]  N. Lawrence,et al.  Effects of alpha-substitutions on structure and biological activity of anticancer chalcones. , 2006, Bioorganic & medicinal chemistry letters.

[36]  E. Hijová.  Bioavailability of chalcones. , 2006, Bratislavske lekarske listy.